Your browser doesn't support javascript.
loading
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.
Brown, Landon C; Halabi, Susan; Schonhoft, Joseph D; Yang, Qian; Luo, Jun; Nanus, David M; Giannakakou, Paraskevi; Szmulewitz, Russell Z; Danila, Daniel C; Barnett, Ethan S; Carbone, Emily A; Zhao, Jimmy L; Healy, Patrick; Anand, Monika; Gill, Audrey; Jendrisak, Adam; Berry, William R; Gupta, Santosh; Gregory, Simon G; Wenstrup, Richard; Antonarakis, Emmanuel S; George, Daniel J; Scher, Howard I; Armstrong, Andrew J.
  • Brown LC; Department of Medicine, Duke Prostate and Urologic Cancer Center, Duke Cancer Institute, Duke University, Durham, North Carolina.
  • Halabi S; Department of Medicine, Duke Prostate and Urologic Cancer Center, Duke Cancer Institute, Duke University, Durham, North Carolina.
  • Schonhoft JD; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
  • Yang Q; Epic Sciences, San Diego, California.
  • Luo J; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
  • Nanus DM; Department of Urology, Johns Hopkins University, Baltimore, Maryland.
  • Giannakakou P; Weill Cornell Medical College, New York, New York.
  • Szmulewitz RZ; Weill Cornell Medical College, New York, New York.
  • Danila DC; University of Chicago, Chicago, Illinois.
  • Barnett ES; Weill Cornell Medical College, New York, New York.
  • Carbone EA; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zhao JL; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Healy P; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Anand M; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gill A; Parexel International, Durham, North Carolina.
  • Jendrisak A; Department of Medicine, Duke Prostate and Urologic Cancer Center, Duke Cancer Institute, Duke University, Durham, North Carolina.
  • Berry WR; Epic Sciences, San Diego, California.
  • Gupta S; Epic Sciences, San Diego, California.
  • Gregory SG; Department of Medicine, Duke Prostate and Urologic Cancer Center, Duke Cancer Institute, Duke University, Durham, North Carolina.
  • Wenstrup R; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina.
  • Antonarakis ES; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina.
  • George DJ; Epic Sciences, San Diego, California.
  • Scher HI; Department of Oncology, Johns Hopkins University, Baltimore, Maryland.
  • Armstrong AJ; Department of Medicine, Duke Prostate and Urologic Cancer Center, Duke Cancer Institute, Duke University, Durham, North Carolina.
Clin Cancer Res ; 27(14): 4077-4088, 2021 07 15.
Article en En | MEDLINE | ID: mdl-33820782
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Feniltiohidantoína / Benzamidas / Inestabilidad Cromosómica / Neoplasias de la Próstata Resistentes a la Castración / Androstenos / Células Neoplásicas Circulantes / Nitrilos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Feniltiohidantoína / Benzamidas / Inestabilidad Cromosómica / Neoplasias de la Próstata Resistentes a la Castración / Androstenos / Células Neoplásicas Circulantes / Nitrilos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article